# Kalaris Therapeutics, Inc.: filings

KLRS · Nasdaq · CIK 1754068 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/klrs.md) · [Financials](/companies/klrs/financials.md) · [Filings](/companies/klrs/filings.md) · [Insiders](/companies/klrs/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 319, 144 118, 8-K 71, 3 34, 10-Q 19, CORRESP 13, 425 11, DEF 14A 7, SC 13G/A 7, UPLOAD 7, 10-K 6, DEFA14A 6, S-8 6, SC 13G 6, 4/A 5, EFFECT 5, 424B3 4, ARS 4, 424B5 3, S-3 3, SCHEDULE 13D/A 3, SCHEDULE 13G/A 3, 3/A 2, D 2, POS AM 2, PRE 14A 2, S-4/A 2, SC 13D 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 424B4 1, 5 1, 8-A12B 1, 8-A12B/A 1, CERT 1, DEL AM 1, DRS 1, POSASR 1, RW 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, S-4 1, SC 13D/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:00 ET | [10-Q](/filings/0001193125-26-344532.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344532 |
| 2026-08-11 | 08:05 ET | [8-K](/filings/0001193125-26-343477.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343477 |
| 2026-07-20 | 08:07 ET | [8-K](/filings/0001193125-26-308382.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-308382 |
| 2026-07-17 | 07:05 ET | [8-K](/filings/0001193125-26-306737.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-306737 |
| 2026-07-06 | 16:11 ET | [8-K](/filings/0001193125-26-296190.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-296190 |
| 2026-06-04 | 16:06 ET | [8-K](/filings/0001193125-26-257388.md) | 5.07 Shareholder vote results | 0001193125-26-257388 |
| 2026-05-22 | 19:48 ET | [SCHEDULE 13D/A](/filings/0001699737-26-000012.md) | Ownership report, active investor, amended | 0001699737-26-000012 |
| 2026-05-12 | 16:00 ET | [10-Q](/filings/0001193125-26-219328.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219328 |
| 2026-05-12 | 08:08 ET | [8-K](/filings/0001193125-26-218240.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218240 |
| 2026-04-24 | 16:25 ET | [DEF 14A](/filings/0001193125-26-177362.md) | Proxy statement, period 2026-06-03 | 0001193125-26-177362 |
| 2026-04-10 | 16:02 ET | [8-K](/filings/0001193125-26-151215.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-151215 |
| 2026-03-17 | 16:00 ET | [10-K](/filings/0001193125-26-110659.md) | Annual report, period 2025-12-31 | 0001193125-26-110659 |
| 2026-03-17 | 08:08 ET | [8-K](/filings/0001193125-26-109437.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-109437 |
| 2026-03-09 | 07:15 ET | [8-K](/filings/0001193125-26-097548.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097548 |
| 2026-02-17 | 20:14 ET | [SCHEDULE 13D/A](/filings/0001699737-26-000007.md) | Ownership report, active investor, amended | 0001699737-26-000007 |
| 2025-12-22 | 16:17 ET | [SCHEDULE 13D/A](/filings/0001699737-25-000032.md) | Ownership report, active investor, amended | 0001699737-25-000032 |
| 2025-12-18 | 07:29 ET | [8-K](/filings/0001193125-25-323706.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-323706 |
| 2025-12-17 | 17:19 ET | [8-K](/filings/0001193125-25-322950.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-322950 |
| 2025-11-12 | 16:00 ET | [10-Q](/filings/0001193125-25-277464.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277464 |
| 2025-11-12 | 08:13 ET | [8-K](/filings/0001193125-25-276060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-276060 |
| 2025-11-03 | 07:38 ET | [8-K](/filings/0001193125-25-261697.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-261697 |
| 2025-08-13 | 16:00 ET | [10-Q](/filings/0000950170-25-107979.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107979 |
| 2025-08-13 | 08:16 ET | [8-K](/filings/0001193125-25-179466.md) | 5.07 Shareholder vote results | 0001193125-25-179466 |
| 2025-08-13 | 08:11 ET | [8-K](/filings/0001193125-25-179464.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-179464 |
| 2025-07-01 | 07:30 ET | [DEF 14A](/filings/0001193125-25-153439.md) | Proxy statement, period 2025-08-12 | 0001193125-25-153439 |
| 2025-06-20 | 07:20 ET | [8-K](/filings/0001193125-25-143202.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-25-143202 |
| 2025-05-14 | 16:00 ET | [10-Q](/filings/0000950170-25-071339.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071339 |
| 2025-05-14 | 08:09 ET | [8-K](/filings/0001193125-25-119408.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-119408 |
| 2025-04-16 | 16:18 ET | [8-K](/filings/0001193125-25-082819.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-082819 |
| 2025-04-04 | 08:12 ET | [8-K](/filings/0001193125-25-072869.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-072869 |
| 2025-03-25 | 19:40 ET | [SCHEDULE 13D](/filings/0001415889-25-008979.md) | Ownership report, active investor | 0001415889-25-008979 |
| 2025-03-18 | 17:04 ET | [8-K](/filings/0001193125-25-056725.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-056725 |
| 2025-03-12 | 16:18 ET | [8-K](/filings/0001193125-25-052940.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-052940 |
| 2025-03-07 | 07:30 ET | [10-K](/filings/0000950170-25-035143.md) | Annual report, period 2024-12-31 | 0000950170-25-035143 |
| 2025-01-15 | 16:39 ET | [8-K](/filings/0001193125-25-007077.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-007077 |
| 2025-01-10 | 17:00 ET | [8-K](/filings/0001193125-25-004527.md) | 8.01 Other events | 0001193125-25-004527 |
| 2025-01-10 | 07:42 ET | [8-K](/filings/0001193125-25-004091.md) | 5.07 Shareholder vote results | 0001193125-25-004091 |
| 2024-12-20 | 16:21 ET | [8-K](/filings/0001193125-24-283140.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-283140 |
| 2024-12-06 | 07:23 ET | [DEF 14A](/filings/0001193125-24-271972.md) | Proxy statement, period 2025-01-09 | 0001193125-24-271972 |
| 2024-11-12 | 16:00 ET | [10-Q](/filings/0000950170-24-125295.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125295 |
| 2024-11-08 | 08:26 ET | [8-K](/filings/0001193125-24-253747.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-253747 |
| 2024-08-09 | 09:05 ET | [10-Q](/filings/0000950170-24-094380.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094380 |
| 2024-07-02 | 16:15 ET | [8-K](/filings/0001193125-24-174335.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-174335 |
| 2024-06-11 | 17:10 ET | [8-K](/filings/0001193125-24-159226.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-159226 |
| 2024-06-07 | 16:03 ET | [8-K](/filings/0001193125-24-157311.md) | 5.07 Shareholder vote results | 0001193125-24-157311 |
| 2024-06-03 | 16:03 ET | [8-K](/filings/0001193125-24-153013.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-153013 |
| 2024-05-13 | 16:00 ET | [10-Q](/filings/0000950170-24-058607.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058607 |
| 2024-04-23 | 16:05 ET | [DEF 14A](/filings/0001193125-24-106976.md) | Proxy statement, period 2024-06-06 | 0001193125-24-106976 |
| 2024-03-15 | 08:43 ET | [10-K](/filings/0000950170-24-031879.md) | Annual report, period 2023-12-31 | 0000950170-24-031879 |
| 2024-02-12 | 16:34 ET | [8-K](/filings/0001193125-24-032160.md) | 3.01 Delisting notice | 0001193125-24-032160 |

Page 1 of 3. [Older](/companies/klrs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:31 ET. No prices; not investment advice.